A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study of ELI-216 [oxycodone/naltrexone] Controlled-Release Capsules Containing Oxycodone Hydrochloride plus Naltrexone Hydrochloride in Patients with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Hip or Knee

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study of ELI-216 [oxycodone/naltrexone] Controlled-Release Capsules Containing Oxycodone Hydrochloride plus Naltrexone Hydrochloride in Patients with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Hip or Knee

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Nov 2007

At a glance

  • Drugs Oxycodone/naltrexone (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 20 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top